课题基金 / 基金详情

Role of O2 in PDGFRb expression and function in aging.

Role of O2 in PDGFRb expression and function in aging.
O2 在 PDGFRb 表达和衰老功能中的作用。
批准号:
7076042
负责人:
WENDE R REENSTRA
金额:
$16.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-01 至 2008-08-31

项目摘要

项目成果

WENDE R REENSTRA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Our long-term goal is to define the mechanisms responsible for delayed wound healing in aging in hopes of developing novel therapies. Hyperbaric oxygen has long been utilized in treating the difficult to heal wounds and has shown promising results on healing wounds from aging individuals. However, very little is understood about the molecular mechanisms involved. We plan to study the mechanisms involved in HBO's increase in wound healing rates by focusing specifically on the expression and function of the platelet derived growth factor receptor-beta (PDGRB) in fibroblasts. Our laboratory has shown that PDGFRB expression is reduced in fibroblasts derived from older donors. Reduced proliferation correlates to a reduction in functional PDGFRB expressed. Hyperbaric oxygen treatment corrects the age associated defect by increasing both PDGFRB number and proliferation of fibroblasts. Our preliminary studies suggest that HBO upregulates PDGFRB expression through a nitric oxide (NO)-dependent mechanism. NO production is required for proper wound healing and insufficient NO production has been linked to delayed wound healing in both animal and human studies. Our hypothesis is that the age associated dysfunction in PDGFRB expression and function may be corrected by HBO in an NO-dependent manner. We plan to define the oxygen-responsive element(s) (ORE) within the PDGFRB promoter and determine whether these elements function differently in human fibroblasts derived from old, young, and newborn donors. We will focus on our in vitro model system and delineate the role of the fibroblast specifically. Findings from these studies will have important implications for novel therapeutic approaches in aging.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of O2 in PDGFRb expression and function in aging.
  • 批准号:
    7282717
  • 项目类别:
  • 资助金额:
    $15.63万
  • 财政年份:
    2006
  • 负责人:
    WENDE R REENSTRA
  • 依托单位:
THREONINE PHOSPHORYLATION AND EGFR SIGNALING
  • 批准号:
    2871437
  • 项目类别:
  • 资助金额:
    $4.17万
  • 财政年份:
    1999
  • 负责人:
    WENDE R REENSTRA
  • 依托单位:
THREONINE PHOSPHORYLATION AND EGFR SIGNALING
  • 批准号:
    2653717
  • 项目类别:
  • 资助金额:
    $3.28万
  • 财政年份:
    1998
  • 负责人:
    WENDE R REENSTRA
  • 依托单位:
THREONINE PHOSPHORYLATION AND EGFR SIGNALING
  • 批准号:
    2001221
  • 项目类别:
  • 资助金额:
    $3.09万
  • 财政年份:
    1997
  • 负责人:
    WENDE R REENSTRA
  • 依托单位:
国内基金
海外基金
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
  • 批准号:
    82371603
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    陈晓
  • 依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
  • 批准号:
    82370743
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    姜娜
  • 依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
  • 批准号:
    82371585
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    周鲁明
  • 依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
  • 批准号:
    82370774
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    阮渊
  • 依托单位: